OBJECTIVE: Evaluate the costs and benefits of the Boston Children's Hospital Community Asthma Initiative (CAI) program through reduction of Emergency Department (ED) visits and hospitalizations and quality of life (QOL) for patients and their families due to reduced missed school days and work days. METHODS: Cost-benefit analysis was used to determine an adjusted Return on Investment (ROI) for all 102 patients enrolled in the CAI program in the calendar year 2006 after controlling for changes in a comparable population without CAI intervention. A societal ROI (SROI) was also computed by including additional indirect benefits due to reduced missed school days for patients and work days for caregivers. RESULTS: Adjusted cost savings from fewer ED visits and hospitalizations resulted in an adjusted ROI of 1.33 (adjusted Net Present Value, (NPV) of savings = $83,863) during the first 3 years after controlling for factors other than the CAI intervention. When benefits due to reduced missed school days and missed work days were added to adjusted cost savings, the SROI increased to 1.85 (Societal NPV of savings = $215,100). CONCLUSIONS: Multidisciplinary, coordinated disease management programs offer the opportunity to prevent costly complications and hospitalizations for chronic diseases, while improving QOL for patients and families. This cost analysis supports the business case for the provision of proactive community-based asthma services that are traditionally not reimbursed by the fee-for-service health care system.
OBJECTIVE: Evaluate the costs and benefits of the Boston Children's Hospital Community Asthma Initiative (CAI) program through reduction of Emergency Department (ED) visits and hospitalizations and quality of life (QOL) for patients and their families due to reduced missed school days and work days. METHODS: Cost-benefit analysis was used to determine an adjusted Return on Investment (ROI) for all 102 patients enrolled in the CAI program in the calendar year 2006 after controlling for changes in a comparable population without CAI intervention. A societal ROI (SROI) was also computed by including additional indirect benefits due to reduced missed school days for patients and work days for caregivers. RESULTS: Adjusted cost savings from fewer ED visits and hospitalizations resulted in an adjusted ROI of 1.33 (adjusted Net Present Value, (NPV) of savings = $83,863) during the first 3 years after controlling for factors other than the CAI intervention. When benefits due to reduced missed school days and missed work days were added to adjusted cost savings, the SROI increased to 1.85 (Societal NPV of savings = $215,100). CONCLUSIONS: Multidisciplinary, coordinated disease management programs offer the opportunity to prevent costly complications and hospitalizations for chronic diseases, while improving QOL for patients and families. This cost analysis supports the business case for the provision of proactive community-based asthma services that are traditionally not reimbursed by the fee-for-service health care system.
Authors: Jonathan D Campbell; Marissa Brooks; Patrick Hosokawa; June Robinson; Lin Song; James Krieger Journal: Am J Public Health Date: 2015-08-13 Impact factor: 9.308
Authors: Paula M Lantz; George Miller; Corwin N Rhyan; Sara Rosenbaum; Leighton Ku; Samantha Iovan Journal: Milbank Q Date: 2018-06 Impact factor: 4.911
Authors: Christina Crabtree-Ide; Denise F Lillvis; Jing Nie; Maria Fagnano; Reynaldo S Tajon; Paul Tremblay; Jill S Halterman; Katia Noyes Journal: Popul Health Manag Date: 2021-05-14 Impact factor: 2.459
Authors: Aduragbemi Oluwabusayo Banke-Thomas; Barbara Madaj; Ameh Charles; Nynke van den Broek Journal: BMC Public Health Date: 2015-06-24 Impact factor: 3.295
Authors: Stephanie K Y Choi; David R Holtgrave; Jean Bacon; Rick Kennedy; Joanne Lush; Frank McGee; George A Tomlinson; Sean B Rourke Journal: AIDS Behav Date: 2016-06
Authors: Ellen Robin Embick; Daniel D Maeng; Iwona Juskiewicz; Catherine Cerulli; Hugh F Crean; Marsha Wittink; Ellen Poleshuck Journal: Arch Womens Ment Health Date: 2020-06-16 Impact factor: 4.405
Authors: Donald L Chi; Elizabeth T Momany; Michael P Jones; Raymond A Kuthy; Natoshia M Askelson; George L Wehby; Peter C Damiano Journal: BMC Pediatr Date: 2013-10-05 Impact factor: 2.125